Anti-NGF antibodies and uses thereof
US12378308B2 · kind B2 · utility
0Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2024 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Jan 23, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides novel anti-NGF proteins, antibodies, and NGF-binding fragments thereof which inhibit association of NGF with TrkA and/or p75 and are suitable for administration to a canine or feline subject. The invention also provides novel compositions and methods of treating pain or eliciting an analgesic effect in a canine or feline subject, comprising administering an effective amount of an anti-NGF protein, antibody or fragment thereof. The methods and compositions are used to treat or prevent NGF-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.